Site Editor

Leo I. Gordon, MD, FACP


COVID-19 and Aggressive Lymphoma: Frequently Asked Questions Answered by ASH

The American Society of Hematology (ASH) provides answers to frequently asked questions regarding the management of patients with diffuse large B-cell lymphoma (DLBCL) amid the COVID-19 era, including treatment, infection prevention, and vaccination. 

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.